Program by Year
Jim Armitage, MD
Treatment of Follicular Lymphoma: The Role of Transplantation in the Post-Rituximab Era
Koen Van Besien, MD
Standard Therapy for Younger Patients with Mantle-Cell Lymphoma Should Include Stem Cell Transplantation. Pro vs. Con
James Bradner, MD, MSc
Utilizing Chemical Biology to Improve Targeted Therapies in Lymphoma
Elias Campo, MD, PhD
Integrating Molecular Insights into Future Treatments for Mantle Cell Lymphoma
Bouthaina S. Dabaja, MD
Radiotherapy should be standard therapy for primary mediastinal DLBCL Pro vs. Con
Andrew Evens, DO, MS
The Biology and Treatment of Elderly Hodgkin Disease
John Gribben, MD
Importance of Immunity and the Microenvironment in Follicular Lymphoma
Paul A. Hamlin, MD
Evaluation and Treatment of Very Elderly DLBCL
John P. Leonard, MD
Standard Therapy for Younger Patients with Mantle-Cell Lymphoma Should Include Stem Cell Transplantation. Pro vs. Con
Shuo Ma, MD, PhD
The Prognosis and Treatment of Elderly CLL
Christiane Pott, MD
Minimal Residual Disease in MCL and FL: How, Who, and When?
John M. Pagel, MD, PhD
Application of Immunoconjugates in Non-Hodgkin Lymphoma
Sonali M. Smith, MD
Case Presentation & Discussions
George J. Weiner, MD
Increasing the Efficacy of Monoclonal Antibodies
Wyndham H. Wilson, MD, PhD, NIH, NCI
Radiotherapy should be standard therapy for primary mediastinal DLBCL Pro vs. Con
John Anastasi, MD
Grey-Zone Lymphomas
Stephen Ansell, MD, PhD
The Future of Monoclonal Antibodies in Lymphoma: What’s Next?
Steven Bernstein, MD
CNS Prophylaxis: Who and How?
Amy Chadburn, MD
Viral Etiology of Lymphoma
Sandeep S. Dave, MD
MiRNA in NHL
Andrew Evens, DO, MS
Northwestern University
Leo I. Gordon, MD
Purine Analogs in Indolent Lymphoma: Pro Vs. Con
Steve Horwitz, MD
How I Treat: Systemic T-NHL
Brad Kahl, MD
Management of Very High Risk DLBCL: Is There Still a Role for Front-Line Transplant
Peter McLaughlin, MD
Purine Analogs in Indolent Lymphoma: Pro Vs. Con
Ari Melnick, MD
Targeting The Germinal Center: Why and How?
Scott Smith, MD
Management of Very High Risk DLBCL: Is There Still a Role for Front-Line Transplant
Sonali Smith, MD
PI3K/Akt/Mtor Pathway in Lymphoma: Progress Report and Future Outlook
Philippe Solal-Celigny, MD, PhD
Keynote Lecture: Prognosis in Follicular Lymphoma in the Modern Era
Joseph Sparano, MD
HIV and NHL in 2010: State of the Art Approach To Front-Line and Relapsed Disease
Koen van Besien, MD
University of Chicago
Denis Weisenberger, MD
T-NHL: Biology and Prognostic Factors
James Cerhan, MD
Genetic Epidemiology: Implications for the Clinical Practitioner
Ken Cohen, MD
NHL microenvironment
Michael Crump, MD
Cure, Late Effects and Prevention in Hodgkin Lymphoma
Andrew Evens, DO, MS
Rational Pathways to Target in Hodgkin lymphoma
Eric Hsi, MD
Biologic predictors and implications on treatment in follicular lymphoma
Neil Kay, MD
Novel approaches and agents for the treatment of relapsed/refractory CLL
Susan O’Brien, MD
Treatment Options for Newly Diagnosed CLL
Michael Pfreundschuh, MD
Perspectives on Front-line DLBCL--Current Status and the Future
Jorge Romaguera, MD
Treatment of mantle cell lymphoma: is upfront aggressive chemotherapy and/or transplant needed?
Mathias Rummel, MD
Pro-Con: Is there a role for ASCT in follicular lymphoma?
Sonali Smith, MD
University of Chicago
Koen van Besien, MD
Pro-Con: Is there a role for ASCT in follicular lymphoma?
Andreas Rosenwald
Biology and Prognosis of High Grade Lymphomas
Sonali Smith
Treatment options for relapsed DLCL
John Sweetenham
Treatment of High Grade Lymphomas
John Leonard
New Monoclonal Antibodies in NHL
John Byrd
CLL: Integration of Biology and Therapeutic Options
Andrew Evens
Challenging Cases: Elderly Hodgkin Disease and Lymphoma with Hepatitis
Julie Vose
Transformed Lymphoma: Definition, Prognosis, and Treatment
Nancy Lee Harris
Pathology and Classification of Follicular Lymphoma: WHO 2008
Thomas Witzig
Sequencing of Therapies in Follicular Lymphoma
Jane Winter
Vaccine Therapy in Lymphoma: Current State of the Art
Izidore Lossos
Gene Array and Diffuse Large B-Cell Lymphoma
Stephanie Gregory
Localized Diffuse Large B-Cell
Leo I. Gordon
Diffuse Large B-Cell Lymphoma
Lauren Abrey
Primary CNS Lymphoma—The Standard of Care
Koen Van Besien
Secondary CNS Lymphoma: Prevention and Treatment
Sonali M. Smith
Challenging Cases: Relapsed T-cell Lymphoma
Finbarr Cotter
Genetics of Mantle Cell Lymphoma: Clinical Implications
Patrick Stiff
Mantle Cell Lymphoma: Role of Stem Cell Transplantation
Martin Dreyling
Mantle Cell Lymphoma—The Next Steps
Lois Travis
Second Cancers Following Hodgkin Lymphoma
Andrew M. Evens
Hodgkin Lymphoma: Advance Stage Disease
Joachim Yahalom
Evolving Role of RT in Hodgkin’s Lymphoma
Madeleine Kraus
Pathology of Hodgkin’s Lymphoma
Volker Diehl
Treatment of Advanced Hodgkin’s Lymphoma
Joseph M. Connors
Nodular Lymphocyte Predominant Hodgkin’s Lymphoma
Steven T. Rosen
Non Cutaneous T-Cell Lymphoma
Andrew Evens
Challending Cases: Hodgkin Disease with Bulky Disease and Anaplastic T-cell Lymphoma
Koen van Besien
Allogeneic Transplant for Low Grade Lymphoma
Sonali M. Smith
Management of Relapsed Diffuse Large B-Cell Lymphoma
Leo Gordon
Radioimmunotherapy for Low Grade and Aggressive Lymphoma
John Anastasi
Overview on Biology and Classification of Large Cell Lymphoma
Jane N. Winter
Novel Prognostic factors in Large Cell Lymphoma
Sigrid Stroobants
The Use of PET Scanning in Diagnosis and Management of Large Cell Lymphoma
Julie Vose
Monoclonal Antibodies in Aggressive Lymphomas
Wyndham Wilson
The Role of Dose Intensity in Large Cell Lymphoma
Koen van Besien
High Dose Chemotherapy in Large Cell Lymphoma
Emanuele Zucca
Biology and Treatment of Localized MALT Lymphoma
Sonali M. Smith
Management of Disseminated Marginal Zone Lymphoma
Page last update: November 12, 2011
